Kytopen Advances Non-Viral Cellular Engineering Of Macrophages
22 Oct 2024 //
PR NEWSWIRE
Kytopen Names Michael Chiu CEO
08 Aug 2023 //
CONTRACT PHARMA
Kytopen Awarded NIH Grant to Unlock the Power of Engineered NK Cells
16 Jun 2021 //
BUSINESSWIRE